CCM Share Price

Open 4.52 Change Price %
High 4.59 1 Day 0.01 0.22
Low 4.50 1 Week 0.31 7.38
Close 4.51 1 Month 0.22 5.13
Volume 6216 1 Year -0.26 -5.45
52 Week High 5.80
52 Week Low 0.00
CCM Important Levels
Resistance 2 4.59
Resistance 1 4.56
Pivot 4.53
Support 1 4.46
Support 2 4.43
NYSE USA Most Active Stocks
BAC 21.23 -1.26%
BAC 21.23 -1.26%
BAC 21.23 -1.26%
EMC 29.05 0.97%
EMC 29.05 0.97%
EMC 29.05 0.97%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
WSH 47.18 -2.86%
More..
NYSE USA Top Gainers Stocks
POM 26.93 26.79%
POM 26.93 26.79%
CAS 0.51 24.39%
CAS 0.51 24.39%
CAS 0.51 24.39%
CAS 0.51 24.39%
CAS 0.51 24.39%
VNR 0.91 19.74%
VNR 0.91 19.74%
P 13.33 16.11%
More..
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
OIBR 0.17 -43.33%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
More..

Concord Medical Services Holdings Limited (NYSE: CCM)

CCM Technical Analysis 4
As on 2nd Dec 2016 CCM Share Price closed @ 4.51 and we RECOMMEND Buy for LONG-TERM with Stoploss of 4.38 & Strong Buy for SHORT-TERM with Stoploss of 4.25 we also expect STOCK to react on Following IMPORTANT LEVELS.
CCM Target for December
1st Target up-side 4.8
2nd Target up-side 4.99
3rd Target up-side 5.19
1st Target down-side 4.24
2nd Target down-side 4.05
3rd Target down-side 3.85
CCM Other Details
Segment EQ
Market Capital 221122480.00
Sector Healthcare
Industry Hospitals
Offical website http://www.cmsholdings.com
CCM Address
CCM
Tower A, Global Trade Center
18th Floor
Beijing, 100013
China
Phone: 86 10 5903 6688
Fax: 86 10 5957 5252
CCM Latest News
Interactive Technical Analysis Chart Concord Medical Services Holdings Limited ( CCM NYSE USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Concord Medical Services Holdings Limited
CCM Business Profile
Concord Medical Services Holdings Limited, through its subsidiaries, operates radiotherapy and diagnostic imaging centers. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, CyberKnife robotic radiosurgery system, proton beam therapy, and diagnostic imaging services. The company also offers other treatments and diagnostic services through the use of medical equipment comprising electroencephalography for the diagnosis of epilepsy; thermotherapy for pain relief after radiotherapy and chemotherapy; ultrasound therapy for the treatment of cancer; stereotactic radiofrequency ablation for the treatment of Parkinson’s disease; and refraction and tonometry for the diagnosis of ophthalmic conditions. In addition, it provides clinical support services, such as developing treatment protocols for doctors; and organizing joint diagnosis between doctors in its network and clinical research. Further, the company offers radiotherapy and diagnostic equipment leasing and management services to hospitals, as well as is engaged in the sale of medical equipment. The company, through its subsidiaries, holds 52% equity interest in Chang’an Hospital, a non-public general hospital with 1,100 hospital beds located in Xi’an, Shaanxi Province. It also focuses on establishing the Beijing Proton Medical Center that would offer radiotherapy treatment options to cancer patients; and Guangzhou Concord Medical Cancer Hospital, a 400-bed specialty hospital for cancer diagnosis and treatment, as well as other specialty cancer hospitals that would offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2013, its network comprised 144 centers based in 81 hospitals, spanning 55 cities across 25 provinces and administrative regions in China. The company was founded in 1996 and is headquartered in Beijing, the People’s Republic of China.